PuriCore Withdraws from Bankruptcy Auction for ECT Patents and Separately Announces $3 Million in New Debt

MALVERN, PENNSYLVANIA, AND STAFFORD, UK, 1 July 2008 — PuriCore (LSE: PURI), the life sciences company focused on the control of infectious pathogens with its novel, safe antimicrobial technology, today announces that it chose to cease bidding in the bankruptcy auction for the patents of Electro-Chemical Technologies Ltd. (“ECT”) (pending patent acquisition announced 20 February 2008). The bidding price for the assets exceeded the Company’s valuation, removing the original opportunity the patents belied. The bankruptcy court approved the sale of the assets to private investors yesterday.